FDA.reportPublic FDA data

Cinvanti 130 MG per 18 ML Injection

RxCUI
1995155
RxNorm name
Cinvanti 130 MG per 18 ML Injection
Display name
Cinvanti 130 MG per 18 ML Injection
Full name
Cinvanti 130 MG per 18 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CINVANTIAPREPITANTHeron Therapeutics, Inc.4c218d3a-a508-4abc-9ed8-a6e8e191d1b42026-04-01Warnings, Adverse reactionsExact identifier
rxcui: 1995155

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c218d3a-a508-4abc-9ed8-a6e8e191d1b4CINVANTI 130 MG in 18 ML Injection [PSN] · 18 ML aprepitant 7.2 MG/ML Injection [Cinvanti] [SBD] · Cinvanti 130 MG per 18 ML Injection [SY] · Cinvanti 7.2 MG/ML per 18 ML Injection [SY]415These highlights do not include all the information needed to use CINVANTI ® safely and effectively. See full prescribing information for CINVANTI. CINVANTI ® (aprepitant) injectable emulsion, for intravenous use Initial U.S. Approval: 200320260401